103 related articles for article (PubMed ID: 30044032)
1. Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation.
Pagliari MT; Baronciani L; Stufano F; Colpani P; Siboni SM; Peyvandi F
Haemophilia; 2018 Jul; 24(4):e263-e266. PubMed ID: 30044032
[No Abstract] [Full Text] [Related]
2. An update on type 2B von Willebrand disease.
Mikhail S; Aldin ES; Streiff M; Zeidan A
Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
[TBL] [Abstract][Full Text] [Related]
3. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
[No Abstract] [Full Text] [Related]
5. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
Othman M
Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
[TBL] [Abstract][Full Text] [Related]
6. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
Franchini M; Montagnana M; Lippi G
Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
[TBL] [Abstract][Full Text] [Related]
7. 2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease.
Whalley IN; Perry DJ
Br J Haematol; 2007 Jan; 136(2):345; author reply 345-6. PubMed ID: 17233824
[No Abstract] [Full Text] [Related]
8. Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.
Rugeri L; Fretigny M; Dargaud Y; Nougier C; Vinciguerra C
Haemophilia; 2016 Sep; 22(5):e439-43. PubMed ID: 27353798
[No Abstract] [Full Text] [Related]
9. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor.
Pelkmans L; Miszta A; Al Dieri R; de Laat B; Kelchtermans H
Thromb Haemost; 2015 Jan; 113(1):209-11. PubMed ID: 25274249
[No Abstract] [Full Text] [Related]
11. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
12. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
13. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
14. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
15. Thrombocytopenia Pitfalls: Misdiagnosing Type 2B von Willebrand Disease as Ethylenediaminetetraacetic Acid-Dependent Pseudothrombocytopenia.
Kumar R; Creary S; Varga EA; Kahwash SB
J Pediatr; 2016 Aug; 175():238-238.e1. PubMed ID: 27215777
[No Abstract] [Full Text] [Related]
16. [Information on von Willebrand disease].
Nishino M; Fujimura Y
Rinsho Byori; 1997 Oct; 45(10):942-50. PubMed ID: 9369071
[TBL] [Abstract][Full Text] [Related]
17. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.
Enayat MS; Guilliatt AM; Lester W; Wilde JT; Williams MD; Hill FG
Br J Haematol; 2006 Jun; 133(6):664-6. PubMed ID: 16704444
[TBL] [Abstract][Full Text] [Related]
19. Case Report: An Infant with Severe Thrombocytopenia Diagnosed with Type 2B von Willebrand Disease Due To a De Novo p.Val1316Met Mutation.
Fan J; Ling J; Zhou H; He J; Hu S
Turk J Haematol; 2020 Nov; 37(4):296-298. PubMed ID: 32618441
[No Abstract] [Full Text] [Related]
20. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
Casari C; Paul DS; Susen S; Lavenu-Bombled C; Harroche A; Piatt R; Poe KO; Lee RH; Bryckaert M; Christophe OD; Lenting PJ; Denis CV; Bergmeier W
Blood Adv; 2018 Jun; 2(12):1417-1428. PubMed ID: 29925524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]